{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Gilead Sciences", "item": "https://www.patentleaderboard.com/2021/company/gilead-sciences"}, {"@type": "ListItem", "position": 4, "name": "Samuel E. Metobo", "item": "https://www.patentleaderboard.com/2021/inventor/fl:sa_ln:metobo-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SM

Samuel E. Metobo — 2 Patents in 2021

GSGilead Sciences: 2 patents #54 of 206Top 30%
Newark, CA: #37 of 186 inventorsTop 20%
California: #13,721 of 66,859 inventorsTop 25%
Overall (2021): #115,911 of 548,734Top 25%
2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10988498 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs Thomas Butler, Aesop Cho, Benjamin R. Graetz, Choung U. Kim, Oliver L. Saunders +3 more 2021-04-27 $236,030,000
10899735 PD-1/PD-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more 2021-01-26 $775,784,000